![Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF](https://www.researchgate.net/publication/306415473/figure/fig1/AS:398595472805937@1472043974795/Box-plots-of-FibroTest-a-ActiTest-b-and-SteatoTest-c-according-to-the-respective_Q320.jpg)
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF
![How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ef306ace42db03995f659a9d2bbe66b9e3c84cc7/6-Table3-1.png)
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
![Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings](https://www.mayoclinicproceedings.org/cms/asset/f31fe019-b030-441a-ae05-df37b814e8c8/figs1.jpg)
Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers - Mayo Clinic Proceedings
![Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine | SpringerLink Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10916-020-01693-5/MediaObjects/10916_2020_1693_Fig1_HTML.png)
Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine | SpringerLink
![How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ef306ace42db03995f659a9d2bbe66b9e3c84cc7/5-Figure6-1.png)
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
![PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis](https://www.researchgate.net/publication/329420467/figure/fig3/AS:736159487504385@1552525507318/Decrease-of-steatosis-NASH-and-fibrosis-biomarkers-in-the-selonsertib-trial-a-d_Q320.jpg)
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
![PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis](https://i1.rgstatic.net/publication/329420467_The_diagnostic_performance_of_a_simplified_blood_test_SteatoTest-2_for_the_prediction_of_liver_steatosis/links/5c89a8c045851564fadc9262/largepreview.png)
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
![How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ef306ace42db03995f659a9d2bbe66b9e3c84cc7/3-Table1-1.png)
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
![The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. - Abstract - Europe PMC The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6380449/bin/meg-31-393-g001.jpg)
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. - Abstract - Europe PMC
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data | PLOS ONE
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://www.mdpi.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g001.png)
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
![Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379120302019-gr5.jpg)
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
![Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-018-0014-9/MediaObjects/41575_2018_14_Fig1_HTML.jpg)
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology
![Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1665268119313870:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNeKOJqKH5+Za6P+RA5Vq9Dls5u0iXC5LbCavFedxYQSP+8lf9HWty7VpSV5WiyPoE9bbcu0Q8uLMiOnXe9iWsk9K2e5u3BX0Q+yJ0aGSj1NJ1SmXBW6x+WD5CR8Og+CC6TUVQLRE2lzZUPQ+lI99+3sGA4lF/TxzqB/PhwgIKKqUy1kJtyjuOcffX4hCJx4MWhKB/mhmfNSa1fTmT4HLwvsjJYW1SLEJlzd/u869mgsonkanYKqQnu2Froffv6OBdI=)
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
![Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine](https://jim.bmj.com/content/jim/67/2/303/F2.large.jpg)
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
![Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - ScienceDirect Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149291821002563-gr1.jpg)
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications - ScienceDirect
![How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ef306ace42db03995f659a9d2bbe66b9e3c84cc7/5-Figure4-1.png)
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
![Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis](https://www.frontiersin.org/files/Articles/774079/fmed-08-774079-HTML/image_m/fmed-08-774079-g001.jpg)
Frontiers | MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
![How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ef306ace42db03995f659a9d2bbe66b9e3c84cc7/4-Figure2-1.png)